While bladder tumors with a luminal subtype and/or FGFR3 mutations have both been associated with a non–T cell–inflamed tumor microenvironment, whether FGFR3 alterations functionally mediate this non–T cell–inflamed phenotype has not been directly explored (17, 18). Here, FGFR3 is linked to neoplasm.